BMY:NYSE
Bristol-Myers Squibb Co
$ 61.15
arrow_upward
+0.53%(+0.32) 1D
$ 61.02
arrow_downward
-0.21% (-0.13)bedtimeAfter hours
Closed: 10-р сарын 2, 16:00:05 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BMY...
Open
$ 60.66
High
$ 61.24
Low
$ 60.24
Mkt. cap
124.91Т
Avg. vol.
10.41 сая
Volume
9.94 сая
Dividend
4.12%
Quarterly dividend
$ 0.63
Ex-dividend date
2026 оны 10-р сарын 2
P/E ratio
13.47
52-wk high
$ 68.64
52-wk low
$ 42.52
EPS
$ 4.54
Beta
0.19
Shares outstanding
2.04 тэрбум
No. of employees
32 мян
Open
$ 60.66
High
$ 61.24
Low
$ 60.24
Mkt. cap
124.91Т
Avg. vol.
10.41 сая
Volume
9.94 сая
Dividend
4.12%
Quarterly dividend
$ 0.63
Ex-dividend date
2026 оны 10-р сарын 2
P/E ratio
13.47
52-wk high
$ 68.64
52-wk low
$ 42.52
EPS
$ 4.54
Beta
0.19
Shares outstanding
2.04 тэрбум
No. of employees
32 мян
News stories
From web sources and news partners
AD HOC NEWS
·
6 цагийн өмнө
Bristol Myers Squibb stock faces a key October 29 results date
Insider Monkey
·
13 цагийн өмнө
AbbVie (ABBV) vs Bristol Myers (BMY): Which is a Better Stock to Buy?
AD HOC NEWS
·
18 цагийн өмнө
Bristol Myers Squibb stock reports 6 percent Q2 revenue growth
The Motley Fool
·
1 өдрийн өмнө
Bristol Myers Squibb Now Trades at Only 9.4X Forward Earnings -- Is This Value Stock a Buy?
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Co
CEOChris Boerner
Employees32.5 мян
Founded1887
HeadquartersНью-Йорк хот, Нью-Йорк Муж Улс, Америкийн Нэгдсэн Улс
SectorPharmaceutical industry
Websitebms.com